Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Clinical trial NCT04065555 · COMPLETED
Trial details
- NCT number
- NCT04065555
- Sponsor
- Presage Biosciences
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-06-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.